| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 02/22/2001 | WO2001012778A2 Flocculation of cell material |
| 02/22/2001 | WO2001012598A2 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 02/22/2001 | WO2001012127A2 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 02/22/2001 | DE19937348A1 Nukleinsäuremoleküle aus Pflanzen codierend Enzyme, die an der Stärkesynthese beteiligt sind Nucleic acid molecules encoding enzymes from plants, which are involved in starch synthesis |
| 02/22/2001 | CA2733616A1 Process for the biological production of 1,3-propanediol with high titer |
| 02/22/2001 | CA2382239A1 Screening for udp-glucose: glycoprotein glucosyltransferase (uggt) activity |
| 02/22/2001 | CA2382095A1 Methods of inhibiting binding of .beta.-sheet fibril to rage and consequences thereof |
| 02/22/2001 | CA2381927A1 Herbicide-tolerant protoporphyrinogen oxidase |
| 02/22/2001 | CA2381427A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
| 02/22/2001 | CA2380652A1 Flocculation of cell material |
| 02/22/2001 | CA2380635A1 Tgf-.alpha. polypeptides, functional fragments and methods of use therefor |
| 02/22/2001 | CA2379196A1 Rotavirus vaccine formulations |
| 02/22/2001 | CA2378173A1 Nucleic acid molecules derived from plants which code for enzymes which are involved in the synthesis of starch |
| 02/22/2001 | CA2347094A1 Microorganisms that extracellulary secrete lipids and methods of producing lipid and lipid vesicles encapsulating lipids using said microorganisms |
| 02/21/2001 | EP1077263A1 Process for producing natural folded and secreted proteins by co-secretion of chaperones |
| 02/21/2001 | EP1077262A1 Process for the production of naturally folded and secreted proteins by co-secretion of molecular shaperones |
| 02/21/2001 | EP1077261A2 A process for the fermentative preparation of metabolic products and for the nucleotide sequences encoding sod |
| 02/21/2001 | EP1077068A1 Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
| 02/21/2001 | EP1076713A1 Human bmp-7 promoter and method for exploring bone-related substance by using the same |
| 02/21/2001 | EP1076708A2 Method for the production of 1,3-propanediol by recombinant organisms comprising genes for vitamin b 12 transport |
| 02/21/2001 | EP1076707A1 PLASMID FOR GENE EXPRESSION IN $i(PICHIA CIFERRII) AND TRANSFORMATION METHOD USING THE SAME |
| 02/21/2001 | EP1076664A2 Human bmp-4 promoter and method for exploring bone-related substance by using the same |
| 02/21/2001 | EP1076662A2 Polyepitope carrier protein |
| 02/21/2001 | EP1076566A1 ATTENUATED MUTANTS OF $i(SALMONELLA) WHICH CONSTITUTIVELY EXPRESS THE Vi ANTIGEN |
| 02/21/2001 | EP0784683B1 Tie-2 ligands, methods of making and uses thereof |
| 02/21/2001 | EP0725825B1 Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains |
| 02/21/2001 | EP0526452B1 Hybrid immunoglobulins |
| 02/21/2001 | CN1285000A Equine infections anaemia virus (EIAV) based |
| 02/21/2001 | CN1284995A Tissue cement proteins from rhipicephalus appendiculatus |
| 02/21/2001 | CN1284994A Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria |
| 02/21/2001 | CN1284560A Fermentation prep. of metabolic products and nucleotide sequence of code sod gene |
| 02/20/2001 | US6191261 Immunoglobulin that preferential binds a growth factor; for the diagnosis and treatment of cell proliferative defects; antiproliferative agents |
| 02/20/2001 | US6191104 Methods of treating graft rejection with the IL-17 receptor |
| 02/20/2001 | US6190914 Methods for modulating metabolic pathways of micro-organisms and micro-organisms obtainable by said methods |
| 02/20/2001 | US6190907 Nucleotide sequences for the transfer of heterologous genes; for treatment of human defects |
| 02/20/2001 | US6190905 Cleaning contact lens; incubating contact lens with proteolytic enzyme, wash several times in buffer, store for utilization |
| 02/20/2001 | US6190904 High-alkaline protease and its use arginine-substituted subtilisin composition and use |
| 02/20/2001 | US6190903 Bacteria having ATCC No. 55926 or ATCC No. 202050 capable of biodegradation of wastes |
| 02/20/2001 | US6190892 Microbial production of indigo |
| 02/20/2001 | US6190891 Process for producing high-molecular-weight phenolic compounds with myrothecium |
| 02/20/2001 | US6190888 Process for making riboflavin glucoside |
| 02/20/2001 | US6190886 Trimerizing polypeptides, their manufacture and use |
| 02/20/2001 | US6190881 Polynucleotide; recombinant production; drug screening of bactericides and enzyme inhibitors |
| 02/20/2001 | US6190880 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 02/20/2001 | US6190879 Culturing microorganism in liquid, measuring ability of broth to incorporate putrescine into casein, measuring ability to convert hydroxylamine to hydroxamic acid, and selecting microorganisms which only catalyze casein formation |
| 02/20/2001 | US6190871 Determining efficacy of monoclonal antibody to neutralize primary isolates by culturing various concentrations of antibody with virus and h9 cells, determining concentration of p24 antigen as indicator of infection, and comparing |
| 02/20/2001 | US6190860 Method to detect CMV by hybridization with a gp55 specific DNA probe |
| 02/20/2001 | US6190669 Attenuated mutants of salmonella which constitutively express the Vi antigen |
| 02/20/2001 | US6190667 Contacting parental helicobacter strain with molecule in biological sample and contacting helicobacter strain deficient in urei gene with molecule; comparing acidity sensitivity of both strains; selecting molecule that increases acidity |
| 02/20/2001 | US6190666 Can be used to transform animal cells for use in efficient production of desired products, such as proteins and vaccines |
| 02/20/2001 | US6190662 Materials and methods relating to the attachment and display of substances on cell surfaces |
| 02/20/2001 | CA2206399C Method for secreting thrombopoietin polypeptides |
| 02/20/2001 | CA2205413C Detergent compositions containing specific lipolytic enzymes |
| 02/20/2001 | CA2119651C Immunoassay for identifying alcoholics and monitoring alcohol consumption |
| 02/20/2001 | CA2043536C Tumor cell growth inhibitor |
| 02/20/2001 | CA1341182C Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 02/20/2001 | CA1341181C Vaccines based on membrane bound proteins and process for making them |
| 02/15/2001 | WO2001011075A2 Pcr-based detection and quantification of tapesia yallundae and tapesia acuformis |
| 02/15/2001 | WO2001011064A2 Polynucleotides regulating the activation of the expression of a gene in the heart and its uses in gene therapy |
| 02/15/2001 | WO2001011060A2 Method of isolating secretion signals in lactic acid bacteria and novel secretion signals isolated from lactococcus lactis |
| 02/15/2001 | WO2001011057A1 Production of proteins |
| 02/15/2001 | WO2001011056A1 Production of proteins by autoproteolytic cleavage |
| 02/15/2001 | WO2001011054A1 CRYSTALLIZATION AND STRUCTURE DETERMINATION OF STAPHYLOCOCCUS AUREUS UDP-N-ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE (S. AUREUS MurB) |
| 02/15/2001 | WO2001011053A2 Soluble, active recombinant human mao-b |
| 02/15/2001 | WO2001011052A2 Monocellular or multicellular organisms for the production of riboflavin |
| 02/15/2001 | WO2001011045A1 A human lactoferrin produced by using an insect cell and method using the same |
| 02/15/2001 | WO2001011040A1 Tumor-associated antigen (r11) |
| 02/15/2001 | WO2001011034A2 Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs |
| 02/15/2001 | WO2001011025A2 Crystallization and structure determination of staphylococcus aureus thymidylate kinase |
| 02/15/2001 | WO2001011024A2 Bryostatins, bryopyrans and polyketides: compositions and methods |
| 02/15/2001 | WO2001011018A2 Avian blastodermal cell lines |
| 02/15/2001 | WO2001011017A2 Materials and methods for the efficient production of pasteuria |
| 02/15/2001 | WO2001011006A2 Detection of micro-organisms |
| 02/15/2001 | WO2001010319A1 Method and apparatus for intracellular electro-manipulation |
| 02/15/2001 | WO2000068376B1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same |
| 02/15/2001 | WO2000063403A3 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein |
| 02/15/2001 | WO2000058482A3 Transducing phages |
| 02/15/2001 | WO2000056866A3 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 02/15/2001 | WO1999066079A9 Detection of non-viral organisms with srp rna |
| 02/15/2001 | WO1999057128A8 Optimization of pest resistance genes using dna shuffling |
| 02/15/2001 | DE19936003A1 Lentivirus aus der Gruppe der Immunschwächeviren der Drillaffen(mandrillus leucophaeus) und ihre Verwendung Lentivirus from the group of immunodeficiency viruses of the drill monkey (mandrillus leucophaeus) and their use |
| 02/15/2001 | CA2383230A1 Tumor-associated antigen (r11) |
| 02/15/2001 | CA2381399A1 Avian blastodermal cell lines |
| 02/15/2001 | CA2381325A1 Polynucleotides regulating the activation of the expression of a gene in the heart and its uses in gene therapy |
| 02/15/2001 | CA2381290A1 Bryostatins, bryopyrans and polyketides: compositions and methods |
| 02/15/2001 | CA2381204A1 Pcr-based detection and quantification of tapesia yallundae and tapesia acuformis |
| 02/15/2001 | CA2380302A1 Production of proteins by autoproteolytic cleavage |
| 02/15/2001 | CA2379998A1 Soluble, active recombinant human mao-b |
| 02/15/2001 | CA2379601A1 Materials and methods for the efficient production of pasteuria |
| 02/15/2001 | CA2379166A1 Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms instrastrand base pairs |
| 02/15/2001 | CA2378032A1 Crystallization and structure determination of staphylococcus aureus udp-n-acetylenolpyruvylglucosamine reductase (s. aureus murb) |
| 02/15/2001 | CA2378010A1 Crystallization and structure determination of staphylococcus aureus thymidylate kinase |
| 02/14/2001 | EP1076094A2 Plasmid capable of autonomous replication in coryneform bacteria |
| 02/14/2001 | EP1075532A1 Partially deleted adenoviral vectors |
| 02/14/2001 | EP1075531A1 Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery |
| 02/14/2001 | EP1075505A1 An acidic cleaning composition comprising an acidic protease |
| 02/14/2001 | EP0851932B1 Plasmid stabilization |
| 02/14/2001 | EP0576590B1 Response element compositions and assays employing same |
| 02/14/2001 | CN1284134A Methods of producing anti-angiogenic proteins: endostation, angiostation or restin, using pichia yeast expression system |
| 02/14/2001 | CN1284130A Mutants of endostation, 'EM1' having ant-angiogenic activety and methods of use thereof |